Genes Heme Flashcards

0
Q

AML unfavorable karyotype and mutations

A

inv(3), -5/del(5q-), -7
LOW NUMBERS AND MINUS SIGNS ARE BAD IN AML

ALSO FLT3 (tyrosine R kinase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

AML favorable karyotype and mutns

A

t(8;21), t(15;17), inv(16)

NMP1 is good (no problem man!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

aPML promyelocytic AML M3

A

t(15;17)

retinoic acid gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MDS UNFAVORABLE

A

chr 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MDS FAVORABLE

A

5q- and 20q-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CMML:what genes suggest favorable response to imatinib (gleevec)

A

t(15;12) (q33;p13)

PDGFRB platelet derived growth factor b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Jak 2 mutn

A

PV, ET, AMM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

gene CML

A

t(9;22), BCR-abl protein, a tyrosine kinase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

incr LAP score (leukocyte alkaline phosphatase)

A

PV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

decr. LAP score (leukocyte alkaline phosphatase)

A

CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

follicular lymphoma

A

t(14;18)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CLL FAVORABLE

A

13q -
low ZAP 70
low CD38
mutn heavy chain Ig

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CLL POOR PROGNOSIS

A

17p -

11q-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

burkitt

A

t(8;14)

leads to incr C-myc protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

mantle

A

overexpression BCL1 product cyclin d 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

BRCA1 is on what chromosome?

A

17q21

16
Q

BRCA2 is on what chromosome?

A

13 q 12-13

17
Q

BRCA1 have increased risk of

A

BCA 50 to 85% lifetime risk
OVARIAN 40% lifetime
colorectal
prostate

18
Q

BRCA2 have risk of

A

BCA 50 to 85% lifetime risk
ovarian 10 to 20% lifetime
melanoma, pancreatic, prostate

19
Q

Li fraumeni syndrome

A

TP53

20
Q

cowden syndrome

A

PTEN

in tuberous sclerosis family